- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Selinexor, bortezomib, and dexamethasone versus bortezomib & dexamethasone in previously treated MM
IACH Journal Club:
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
Dr. Richard Shambavi, Dr. Salomon Mainer, Prof. Mohamad Mohty
July 20, 2021
Видео Selinexor, bortezomib, and dexamethasone versus bortezomib & dexamethasone in previously treated MM канала International Academy for Clinical Hematology IACH
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
Dr. Richard Shambavi, Dr. Salomon Mainer, Prof. Mohamad Mohty
July 20, 2021
Видео Selinexor, bortezomib, and dexamethasone versus bortezomib & dexamethasone in previously treated MM канала International Academy for Clinical Hematology IACH
Комментарии отсутствуют
Информация о видео
27 июля 2021 г. 20:11:14
00:38:34
Другие видео канала
Latest advances in the management of Hodgkin lymphoma
DLI after allogeneic stem cell transplantation: where do we stand?
Allogeneic Stem Cell Transplantation for Myelofibrosis
MM Academy Round table debate
Post COMy-EHA Round table - Unmet Need in RRMM and Emerging Therapies
Post #ASH24: Allo Transplant Studies
The 1st Online Master class in Transplantation and Hematology (MATH) - Session 4
Actualités des conditionnements en allogreffe
Post #ASH24: the Most Important MPN Studies
Vivre avec une GVH
COMy Online 2020 - Session 12 (Oral Abstracts)
GVHD management and Survivorship in HCT recipients
IACH webinar summarizing the best AML ASH25 data - Dec 18 2025
COMy 2026 KOL interview invitation
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis...
CAR-T cells in lymphoma: an update from #ASH25 - Dec 17 2025
Imetelstat in patients with lower-risk MDS
CAR-T cells in lymphoid diseases: the patient journey
The 1st Online Master class in Transplantation and Hematology (MATH) - Session 1
Immunothérapie du myélome multiple: le point de vue des soignants (In French)
